Find Unesbulin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Ptc596, 1610964-64-1, Unesbulin, Ptc-596, Bmi1 inhibitor ptc596, Unesbulin [usan]
Molecular Formula
C19H13F5N6
Molecular Weight
420.3  g/mol
InChI Key
TWLWOOPCEXYVBE-UHFFFAOYSA-N
FDA UNII
Z4HZ70S62Q

Unesbulin
Unesbulin is an orally active inhibitor of the polycomb ring finger oncogene BMI1 (B-cell-specific Moloney murine leukemia virus integration site 1), with potential antineoplastic activity. Upon oral administration, unesbulin targets BMI1 expressed by both tumor cells and cancer stem cells (CSCs), and induces hyper-phosphorylation of BMI1 leading to its degradation. This inhibits BMI1-mediated signal transduction pathways and results in a reduction of proliferation of BMI1-expressing tumor cells. BMI1, a key protein in the polycomb repressive complex 1 (PRC1), is overexpressed in certain tumor cell types, and plays a key role in CSC survival, proliferation and resistance to chemotherapeutics; its expression is associated with increased tumor aggressiveness and a poor prognosis.
1 2D Structure

Unesbulin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-N-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine
2.1.2 InChI
InChI=1S/C19H13F5N6/c1-9-26-13-7-4-11(20)8-14(13)30(9)18-28-16(25)15(21)17(29-18)27-12-5-2-10(3-6-12)19(22,23)24/h2-8H,1H3,(H3,25,27,28,29)
2.1.3 InChI Key
TWLWOOPCEXYVBE-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=NC2=C(N1C3=NC(=C(C(=N3)NC4=CC=C(C=C4)C(F)(F)F)F)N)C=C(C=C2)F
2.2 Other Identifiers
2.2.1 UNII
Z4HZ70S62Q
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 5-fluoro-2-(6-fluoro-2-methyl-1h-benzo(d)imidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine

2. Ptc596

2.3.2 Depositor-Supplied Synonyms

1. Ptc596

2. 1610964-64-1

3. Unesbulin

4. Ptc-596

5. Bmi1 Inhibitor Ptc596

6. Unesbulin [usan]

7. Z4hz70s62q

8. Ptc 596

9. Polycomb Ring Finger Oncogene Inhibitor Ptc596

10. 5-fluoro-2-(6-fluoro-2-methylbenzimidazol-1-yl)-4-n-[4-(trifluoromethyl)phenyl]pyrimidine-4,6-diamine

11. 5-fluoro-2-(6-fluoro-2-methyl-1h-benzo(d)imidazole-1-yl)-n4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine

12. 5-fluoro-2-(6-fluoro-2-methyl-1h-benzimidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)-4,6-pyrimidinediamine

13. 5-fluoro-2-(6-fluoro-2-methyl-1h-benzimidazol-1-yl)-n4-[4-(trifluoromethyl)phenyl]-4,6-pyrimidinediamine

14. Unesbulin [inn]

15. Unesbulin [who-dd]

16. Unii-z4hz70s62q

17. Chembl4594353

18. Schembl15741319

19. Bcp33231

20. Ex-a3263

21. Ptc-596; Ptc 596

22. S8820

23. Who 11570

24. Ac-32587

25. Bs-15871

26. Hy-112041

27. Cs-0042474

28. D83695

29. 4,6-pyrimidinediamine, 5-fluoro-2-(6-fluoro-2-methyl-1h-benzimidazol-1-yl)-n4-(4-(trifluoromethyl)phenyl)-

2.4 Create Date
2014-06-09
3 Chemical and Physical Properties
Molecular Weight 420.3 g/mol
Molecular Formula C19H13F5N6
XLogP34.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count10
Rotatable Bond Count3
Exact Mass420.11218525 g/mol
Monoisotopic Mass420.11218525 g/mol
Topological Polar Surface Area81.6 Ų
Heavy Atom Count30
Formal Charge0
Complexity586
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1610964-64-1 / Unesbulin API manufacturers, exporters & distributors?

Unesbulin manufacturers, exporters & distributors 1

64

PharmaCompass offers a list of Unesbulin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Unesbulin manufacturer or Unesbulin supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Unesbulin manufacturer or Unesbulin supplier.

PharmaCompass also assists you with knowing the Unesbulin API Price utilized in the formulation of products. Unesbulin API Price is not always fixed or binding as the Unesbulin Price is obtained through a variety of data sources. The Unesbulin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Unesbulin

Synonyms

Ptc596, 1610964-64-1, Ptc-596, Bmi1 inhibitor ptc596, Unesbulin [usan], Z4hz70s62q

Cas Number

1610964-64-1

Unique Ingredient Identifier (UNII)

Z4HZ70S62Q

About Unesbulin

Unesbulin is an orally active inhibitor of the polycomb ring finger oncogene BMI1 (B-cell-specific Moloney murine leukemia virus integration site 1), with potential antineoplastic activity. Upon oral administration, unesbulin targets BMI1 expressed by both tumor cells and cancer stem cells (CSCs), and induces hyper-phosphorylation of BMI1 leading to its degradation. This inhibits BMI1-mediated signal transduction pathways and results in a reduction of proliferation of BMI1-expressing tumor cells. BMI1, a key protein in the polycomb repressive complex 1 (PRC1), is overexpressed in certain tumor cell types, and plays a key role in CSC survival, proliferation and resistance to chemotherapeutics; its expression is associated with increased tumor aggressiveness and a poor prognosis.

Unesbulin Manufacturers

A Unesbulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Unesbulin, including repackagers and relabelers. The FDA regulates Unesbulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Unesbulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Unesbulin Suppliers

A Unesbulin supplier is an individual or a company that provides Unesbulin active pharmaceutical ingredient (API) or Unesbulin finished formulations upon request. The Unesbulin suppliers may include Unesbulin API manufacturers, exporters, distributors and traders.

Unesbulin GMP

Unesbulin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Unesbulin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Unesbulin GMP manufacturer or Unesbulin GMP API supplier for your needs.

Unesbulin CoA

A Unesbulin CoA (Certificate of Analysis) is a formal document that attests to Unesbulin's compliance with Unesbulin specifications and serves as a tool for batch-level quality control.

Unesbulin CoA mostly includes findings from lab analyses of a specific batch. For each Unesbulin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Unesbulin may be tested according to a variety of international standards, such as European Pharmacopoeia (Unesbulin EP), Unesbulin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Unesbulin USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty